solasia pharma kk
(4597:Tokyo Stock Exchange)
Bard J. Geesaman Ph.D., M.D.
|Age||Total Calculated Compensation||This person is connected to 12 board members in 4 different organizations across 6 different industries.|
See Board Relationships
Dr. Bard J. Geesaman, M.D., Ph.D., serves as Managing Director of MPM Capital. Dr. Geesaman joined MPM Capital in 2001 as part of the management team for Elixir Pharmaceuticals. He is the Founder of Solasia Pharma KK. In 2006, he joined MPM as a Venture Partner with a major focus on founding Solasia Pharmaceuticals. Previously, he served as an Executive Director of Life Sciences at X PRIZE Foundation, where he was responsible for developing, funding and running new prizes ...
Shiodome BuildingPhone: 81 3 6721 8332
Tokyo, -- 105-0022
Board Members Memberships*
Massachusetts Institute of Technology
University of California Berkeley
Harvard Medical School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.